General MedicationsINTRAMUSCULARGeneric
SEIZALAM
MIDAZOLAM HYDROCHLORIDE
Standard Dose
EQ 50MG BASE/10ML (EQ 5MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview SEIZALAM is listed in Drugs@FDA under application 209566 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MIDAZOLAM HYDROCHLORIDE Form and strength SOLUTION;INTRAMUSCULAR - EQ 50MG BASE/10ML (EQ 5MG BASE/ML) Sponsor MMT Submission history Latest submission status date: 2023-01-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview SEIZALAM is listed in Drugs@FDA under application 209566 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MIDAZOLAM HYDROCHLORIDE Form and strength SOLUTION;INTRAMUSCULAR - EQ 50MG BASE/10ML (EQ 5MG BASE/ML) Sponsor MMT Submission history Latest submission status date: 2023-01-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.